Michael Kramarz is one of the relatively few venture investors who is both a trained physician and co-founder/managing partner of a dedicated biotech investment firm, combining clinical understanding with full-time investing responsibilities at Commodore Capital. His background includes hands-on drug development experience at companies like Celgene and Audentes Therapeutics before launching Commodore, plus highly academic training that runs from a summa cum laude biomedical engineering degree at Duke through an MD from Penn and an MBA in Health Care Management from Wharton.